Anna Maria Buchbauer

Anna Maria Buchbauer is a Researcher at the University Clinic for Pediatrics and Adolescent Medicine. She contributes to clinical research in pediatric gastroenterology, focusing on inflammatory bowel disease (IBD), hydrogen sulfide biology, and intestinal mucosal function. Her work includes developing clinical guidelines, evaluating biologic therapies (e.g., adalimumab), and improving pediatric endoscopy protocols.

Key research areas involve IBD pathophysiology, nutritional interventions, and translational studies. She co-led a 2017-2019 project investigating mitochondrial function in IBD patients. Buchbauer also engages in policy initiatives, such as front-of-package food labeling advocacy to combat diet-related diseases.

Her publications (35+ papers, 2025: 4; 2024: 1) reflect expertise in pediatric gastroenterology, with recent work emphasizing guideline development, clinical trial validation, and therapeutic efficacy assessments. She organized the 2021 Austrian Society for Pediatrics Annual Meeting, demonstrating leadership in academic community engagement.